Intentional and non-intentional non-adherence to medication amongst breast cancer patients.

This study aimed to investigate the prevalence of and factors associated with non-adherence to medication amongst a sample of breast cancer patients. 131 women with stable disease were interviewed and completed standardised psychological measures. 55% of women reported non-adherence to medication frequently or occasionally, with younger women and those who disliked taking their medication being significantly less adherent (P = 0.015, P = 0.001). Women who deliberately omitted taking their tablets occasionally or frequently had significantly lower scores, indicative of a weaker influence, on 'internal' and 'powerful others' dimensions of health locus of control (P = 0.032, P = 0.009). Despite a life-threatening diagnosis, patients may not adhere to medication representing a potential missed opportunity for health gain and waste of resources. Furthermore, interpretation of clinical trial data may be misleading without adherence information. More research is needed to identify those at risk for non-adherence. If other routes of administration are available these options should be discussed with patients to maximise efficacy of therapy.

[1]  N. Iihara,et al.  Beliefs of chronically ill Japanese patients that lead to intentional non‐adherence to medication , 2004, Journal of clinical pharmacy and therapeutics.

[2]  L. Fallowfield,et al.  Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  J. Cuzick,et al.  Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Powles,et al.  Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.

[5]  G. Elwyn,et al.  “Doing prescribing”: how doctors can be more effective , 2003, BMJ : British Medical Journal.

[6]  R. Brian Haynes,et al.  Compliance in Health Care , 1979 .

[7]  J. Weinman,et al.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.

[8]  T. Lash,et al.  Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Aliza K Fink,et al.  Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Mcdonald,et al.  Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.

[11]  L. Fallowfield,et al.  Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments? , 2001, Breast Cancer Research and Treatment.

[12]  E. Winer,et al.  Adherence to therapy with oral antineoplastic agents. , 2002, Journal of the National Cancer Institute.

[13]  Jerry Avorn,et al.  Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Farmer,et al.  Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. , 1999, Clinical therapeutics.

[15]  K. Wallston,et al.  Development and validation of the health locus of control (HLC) scale. , 1976, Journal of consulting and clinical psychology.

[16]  E. Grunfeld,et al.  Adherence beliefs among breast cancer patients taking tamoxifen. , 2005, Patient education and counseling.